ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat bile duct cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, for people with advanced bile duct cancer that had worsened despite standard chemotherapy. The goal was to see if this drug pair could help control the cancer and was safe for patients. It involved 27 par…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested for Tough-to-Treat liver cancers
Disease control CompletedThis study tested the safety and effectiveness of a new immunotherapy drug called SHR-1210 when given with other cancer drugs. It involved 157 people with advanced liver cancer or bile duct cancer who had either tried previous treatments or were newly diagnosed. The main goal was…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC